Insider Transactions in Q4 2023 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2023
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,851
-9.45%
|
$26,553
$3.57 P/Share
|
|
Oct 16
2023
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,835
+18.19%
|
-
|
|
Oct 16
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,395
-4.13%
|
$4,185
$3.57 P/Share
|
|
Oct 16
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+7.69%
|
-
|
|
Oct 16
2023
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,395
-4.65%
|
$4,185
$3.57 P/Share
|
|
Oct 16
2023
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+8.57%
|
-
|